Clinical Trial Update: Evaluation of Two Doses of QVAR by Breath Operated and Metered Dose Inhalers in Asthmatic Children [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating two doses of QVAR delivered by breath-activated and metered-dose inhalers in children with asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• QVAR (beclomethasone dipropionate inhalation aerosol)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED